NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 324 filers reported holding NOVAVAX INC in Q2 2022. The put-call ratio across all filers is 1.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $85 | +10.4% | 11,807 | +14.6% | 0.00% | 0.0% |
| Q2 2023 | $77 | +8.5% | 10,307 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $71 | -40.3% | 10,307 | -10.9% | 0.00% | -42.9% |
| Q4 2022 | $119 | -99.9% | 11,562 | +2.5% | 0.01% | -41.7% |
| Q3 2022 | $205,000 | -63.7% | 11,282 | +3.0% | 0.01% | -61.3% |
| Q2 2022 | $564,000 | -15.1% | 10,957 | +21.5% | 0.03% | +3.3% |
| Q1 2022 | $664,000 | -13.0% | 9,017 | +69.0% | 0.03% | -9.1% |
| Q4 2021 | $763,000 | -15.8% | 5,336 | +22.1% | 0.03% | -23.3% |
| Q3 2021 | $906,000 | +14.5% | 4,369 | +17.3% | 0.04% | +16.2% |
| Q2 2021 | $791,000 | +20.4% | 3,724 | +2.8% | 0.04% | +2.8% |
| Q1 2021 | $657,000 | +34.9% | 3,624 | -17.0% | 0.04% | -16.3% |
| Q4 2020 | $487,000 | +28.8% | 4,365 | +25.1% | 0.04% | +19.4% |
| Q3 2020 | $378,000 | -3.3% | 3,489 | -25.6% | 0.04% | -2.7% |
| Q2 2020 | $391,000 | – | 4,692 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,559,918 | $543,496,000 | 8.72% |
| Foresite Capital Management I, LLC | 66,810 | $14,184,000 | 8.55% |
| Samsara BioCapital, LLC | 198,600 | $42,165,000 | 5.20% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 330,541 | $70,177,000 | 4.54% |
| Foresite Capital Management II, LLC | 67,373 | $14,304,000 | 3.85% |
| Rock Springs Capital Management LP | 455,000 | $96,601,000 | 1.91% |
| DELTEC ASSET MANAGEMENT LLC | 56,320 | $11,957,000 | 1.65% |
| Parametrica Management Ltd | 10,200 | $2,166,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 88,450 | $18,779,000 | 1.52% |
| TSP Capital Management Group, LLC | 18,525 | $3,933,000 | 1.29% |